Skip to content
  • Mediacenter
  • Literature Database
  • Investor News
  • Careers
  • Get in Contact
International (English)
Locale
CytoSorbents Europe GmbH
International (English)
Locale
Hotline
  • The Therapy
    • Background
    • Fields of application for the CytoSorb Therapy
    • Ticagrelor and Rivaroxaban
    • Therapeutic aspects
    • COVID-19
    • Global decision support
    • Product safety
    • Testimonials
  • CytoScore
  • The Studies
    • Multicenter Studies
    • Monocenter studies
    • The CytoSorb-Registry
    • Case of the Month Submission
  • The Adsorber
    • Setup of CytoSorb
    • Usage and Application
    • Technical data
    • Q&A
  • Events
    • Event review
  • Support
    • Mediacenter
    • Reimbursement & Coding of CytoSorb Therapy
    • More Information about CytoSorb® therapy
    • Newsletter Registration
    • Hotline
  • About us
    • Corporation Management
    • CytoSorbents worldwide
    • Scientific partners
    • 10 Years CytoSorb® Therapy
    • Careers
    • Get in Contact

SIP OF SCIENCE No.5 with Marijana | CytoSorb® Therapy in Cardiac Surgery

Hemoadsorption in cardiac surgery – New data and trends for successful use of CytoSorb

Hämoadsorption in der Herzchirurgie – Neue Daten und Trends für einen erfolgreichen Einsatz von CytoSorb

CytoSorb World Users’ Meeting

Babylon Berlin | 2022

DGTHG 2022: Herausforderung Endokarditis – Welche Patienten profitieren von der CytoSorb-Behandlung?

8. deutschsprachiges CytoSorb Anwendertreffen

8th International CytoSorb Users Meeting

Hemoadsorption with CytoSorb in various cardiac surgery indications

Role of CytoSorb hemoadsorption therapy in endocarditis patients

CytoSorb adsorption for reducing risk of bleeding during cardiac surgery in Ticagrelor/Rivaroxaban

  • 1
  • 2
  • 3
  • ...
  • 9
  • Next
CytoSorbents Europe GmbH
Facebook-f Twitter Linkedin Youtube

CytoSorbents Europe GmbH
Müggelseedamm 131
12587 Berlin

support(at)cytosorbents.com

©2023 CYTOSORBENTS EUROPE GMBH | ALL RIGHTS RESERVED

*CytoSorb Therapy is the use of the CytoSorb adsorber in conditions where elevated levels of Cytokines and/or Bilirubin and/or Myoglobin exist. CytoSorb can also be used intraoperatively for the removal of Ticagrelor and/or Rivaroxaban during Cardiopulmonary-Bypass.

  • Privacy Information
  • Data protection
  • Disclaimer
  • Imprint
CytoSorbents Europe GmbH
  • The Therapy
    • Background
    • Fields of application for the CytoSorb Therapy
    • Ticagrelor and Rivaroxaban
    • Therapeutic aspects
    • COVID-19
    • Global decision support
    • Product safety
    • Testimonials
  • CytoScore
  • The Studies
    • Multicenter Studies
    • Monocenter studies
    • The CytoSorb-Registry
    • Case of the Month Submission
  • The Adsorber
    • Setup of CytoSorb
    • Usage and Application
    • Technical data
    • Q&A
  • Events
    • Event review
  • Support
    • Mediacenter
    • Reimbursement & Coding of CytoSorb Therapy
    • More Information about CytoSorb® therapy
    • Newsletter Registration
    • Hotline
  • About us
    • Corporation Management
    • CytoSorbents worldwide
    • Scientific partners
    • 10 Years CytoSorb® Therapy
    • Careers
    • Get in Contact
APPLY TODAY
JOBS
International (English)
  • Privacy Policy
  • Data protection
  • Disclaimer
  • Imprint